New tirapazamine derivatives protect cardiomyocytes from doxorubicin toxicity

1. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004; 56:185-229.10.1124/pr.56.2.615169927Search in Google Scholar

2. Carvalho FS, Burgeiro A, Garcia R, Moreno AJ, Carvalho RA, Oliveira PJ. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy. Med Res Rev. 2014;34: 106-35.10.1002/med.2128023494977Search in Google Scholar

3. Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC, Perry MC. Cardiotoxicity of cancer therapy. J Clin Oncol. 2005;23:7685-96.10.1200/JCO.2005.08.78916234530Search in Google Scholar

4. Sardao, VA, Oliveira PJ, Holy J, Oliveira CR, Wallace KB. Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets. Cell Biol Toxicol. 2009;25:227-43.10.1007/s10565-008-9070-118386138Search in Google Scholar

5. Torres VM, Simic VD. Doxorubicin-Induced Oxidative Injury of Cardiomyocytes – Do We Have Right Strategies for Prevention? In: M. Fiuza (ed). Cardiotoxicity of Oncologic Treatments. London: Intech Open; 2012.Search in Google Scholar

6. Zhang J, Cui X, Yan Y, Li M, Yang Y, Wang J, et al. Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity. Am J Transl Res. 2016;8:2862-75.Search in Google Scholar

7. Hicks KO, Siim BG, Jaiswal JK, Pruijn FB, Fraser AM, Patel R, et al. Pharmacokinetic/pharmacodynamic modelling identifies SN30000 and SN29751 as tirapazamine analogues with improved tissue penetration and hypoxic cell killing in tumors. Clin Cancer Res. 2010;16:4946-57.10.1158/1078-0432.CCR-10-1439339097120732963Search in Google Scholar

8. Hong B, Lui VWY, Hui EP, Ng MH, Cheng, SH, Sung FL, et al. Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation. Invest New Drugs. 2011;29:401-10.10.1007/s10637-009-9356-z20013349Search in Google Scholar

9. Reddy SB, Williamson SK. Tirapazamine: a novel agent targeting hypoxic tumor cells. Expert Opin Investig Drugs. 2009;18:77-87.10.1517/1354378080256725019053884Search in Google Scholar

10. Sliwinska J, Dudka J, Korga A, Burdan F, Matysiak W, Jodlowska-Jedrych B, et al. Tirapazamine-doxorubicin interaction referring to heart oxidative stress and Ca²⁺ balance protein levels. Oxid Med Cell Longev. 2012:article ID 890826.10.1155/2012/890826336221122666522Search in Google Scholar

11. Minotti G, Licata S, Saponiero A, Menna P, Calafiore AM, Di Giammarco G, et al. Anthracycline metabolism and toxicity in human myocardium: comparisons between doxorubicin, epirubicin and a novel disaccharide analogue with reduced formation and [4Fe-4S]-reactivity of its secondary alcohol metabolite. Chem Res Toxicol. 2000;13:1336-41.10.1021/tx000143z11123976Search in Google Scholar

12. Halliwell B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol. 2006;141:312-2210.1104/pp.106.077073147543116760481Search in Google Scholar

13. Berthiaume JM, Wallace KB. Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol. 2007;23:15-25.10.1007/s10565-006-0140-y17009097Search in Google Scholar

14. Wouters BG, Delahoussaye YM, Evans JW, Birrell GW, Dorie MJ, Wang J et al. Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine. Cancer Res. 2001;61:145-52.Search in Google Scholar

15. Matysiak W, Dudka J, Korga A, Zięba J, Syroka I, Dawidek-Pietryka K, et al. Effect of tirapazamine on oxidative stress and metabolic parameters in skeletal muscle of rats treated with classic anticancer drugs. Ann UMC Sec DDD. 2010;XXIII(1):12.Search in Google Scholar

16. Ross MF, Kelso GF, Blaikie FH, James AM, Cochemé HM, Filipovska A, et al. Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology. Biochemistry (Mosc). 2005;70:222-30.10.1007/s10541-005-0104-515807662Search in Google Scholar